Experimental Regeneron drug used to treat Trump showed promise in trials

President Donald Trump is being treated with an experimental coronavirus antibody cocktail developed by Regeneron, the White House revealed Friday.  ‘Following PCR-confirmation of the President’s diagnosis, as a precautionary measure, he received a single 8 gram dose of Regneron’s polyclonal antibody cocktail,’ wrote physician to the president, Dr Sean Conley, in a White House memo.  … Read more

Manchester man is first to receive experimental arthritis drug in trial to treat Covid-19 

Coronavirus patient, 41, becomes first in the UK to receive experimental arthritis drug in trial to treat Covid-19 Farhan Hamid, 41, has been in intensive care at Manchester Royal Infirmary Received dose of otilimab – potential arthritis treatment – to see effect on Covid Study trial is being funded by GlaxoSmithKline who aim to recruit 800 patients By … Read more

China quietly lands its ultra-secret experimental spacecraft

There are three major missions bound for Mars in the space of just 10 days this month – the UAE’s Hope orbiter, China’s Tianwen-1 craft and NASA’s Perseverance rover.  The countries are taking advantage of a period when Earth and Mars are favourably aligned for a relatively short journey.   July 20: Hope (UAE) The 3,000lb (1,350kg) craft (pictured) … Read more

Novavax’s experimental coronavirus vaccine triggered antibodies in 100% of trial participants

Novavax’s experimental coronavirus vaccine triggered antibodies in 100% of trial participants, study reveals Novavax published ‘positive data’ from a phase 1 trial of its coronavirus vaccine in the New England Journal of Medicine on Friday  All 108 volunteers dosed with the vaccine developed a antibodies to coronavirus after their second shot  Novavax is launching its … Read more

At least 25 people at nursing homes get experimental covid preventive drug

Big Pharma firm Eli Lilly is testing whether its experimental antibody drug can stop a single infection from turning into a full-blown outbreak in US nursing homes.  The company is running trials of its highly-anticipated monoclonal antibody treatment in a highly unusual study population: elderly Americans in long-term care facilities.  Monoclonal antibodies are modeled after … Read more

Andrew Lloyd Webber gets experimental coronavirus vaccine

Andrew Lloyd Webber received an experimental coronavirus vaccine as part of an Oxford trial on Thursday. The world-renowned composer, 72, shared a snap from hospital via Twitter, which showed a nurse inject him with the vaccination. Looking relaxed as he got the procedure done, Andrew wore a face mask to protect himself amid the COVID-19 crisis … Read more

New experimental coronavirus vaccine boosted antibody levels in mice 90-fold

New experimental coronavirus vaccine prevented severe disease in mice after two doses of the jab boosted their antibody levels 90-fold Researchers genetically modified vesicular stomatitis virus (VSV), which causes a mild illness in livestock, to become a vaccine The team took out a gene from VSV and inserted the spike protein from the coronavirus, which … Read more

Experimental MS drug prevents relapses in nine out of 10 patients

A life-changing treatment for the devastating autoimmune condition, multiple sclerosis (MS), may be on the horizon after signs of the disease completely disappeared from nine out of 10 patients treated with an experimental drug.  More than 900 volunteers with a common form of recurrent MS were given shots of ofatumumab, an drug designed to alter … Read more

Experimental Moderna vaccine may ‘neutralise’ coronavirus

Moderna’s experimental COVID-19 vaccine produced antibodies that could ‘neutralize’ the new coronavirus in patients in a small early stage clinical trial, the company announced Monday, sending its shares up 25 percent.  The levels of the antibodies were similar to those in blood samples of people who have recovered from COVID-19, early results from the study … Read more

NHS will have ‘answers’ on whether experimental coronavirus drugs work by JUNE

The NHS will ‘have answers’ about the effectiveness of promising coronavirus drugs in June, health bosses say. Stephen Powis, NHS England’s national medical director, claimed the first results of clinical trials into the medicines were expected in ‘five to seven weeks’. It comes as Prime Minister Boris Johnson looks set to announce he will keep Britain … Read more